| Literature DB >> 32360900 |
Honghao Zhang1, Yanshuai Zhang1, Masahiko Terajima2, Genevieve Romanowicz1, Yangjia Liu3, Maiko Omi1, Erin Bigelow4, Danese M Joiner4, Erik I Waldorff4, Peizhi Zhu5, Mekhala Raghavan5, Michelle Lynch1, Nobuhiro Kamiya6, Rongqing Zhang7, Karl J Jepsen4, Steve Goldstein4, Michael D Morris5, Mitsuo Yamauchi2, David H Kohn1, Yuji Mishina8.
Abstract
Bone morphogenetic protein (BMP) signaling in osteoblasts plays critical roles in skeletal development and bone homeostasis. Our previous studies showed loss of function of BMPR1A, one of the type 1 receptors for BMPs, in osteoblasts results in increased trabecular bone mass in long bones due to an imbalance between bone formation and bone resorption. Decreased bone resorption was associated with an increased mature-to-immature collagen cross-link ratio and mineral-matrix ratios in the trabecular compartments, and increased tissue-level biomechanical properties. Here, we investigated the bone mass, bone composition and biomechanical properties of ribs and spines in the same genetically altered mouse line to compare outcomes by loss of BMPR1A functions in bones from different anatomic sites and developmental origins. Bone mass was significantly increased in both cortical and trabecular compartments of ribs with minimal to modest changes in compositions. While tissue-levels of biomechanical properties were not changed between control and mutant animals, whole bone levels of biomechanical properties were significantly increased in association with increased bone mass in the mutant ribs. For spines, mutant bones showed increased bone mass in both cortical and trabecular compartments with an increase of mineral content. These results emphasize the differential role of BMP signaling in osteoblasts in bones depending on their anatomical locations, functional loading requirements and developmental origin.Entities:
Keywords: BMP receptor type 1A; Biomechanical properties; Bone quality; Collagen cross-links; Osteoblasts
Mesh:
Substances:
Year: 2020 PMID: 32360900 PMCID: PMC7354232 DOI: 10.1016/j.bone.2020.115402
Source DB: PubMed Journal: Bone ISSN: 1873-2763 Impact factor: 4.398